Total Payments
$11,351
2022 Payments
$907.95
Companies
26
Transactions
322
Medicare Patients
12,809
Medicare Billing
$539,670
Payment Breakdown by Category
Food & Beverage$11,135 (98.1%)
Education$216.05 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,135 | 285 | 98.1% |
| Education | $216.05 | 37 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $2,660 | 82 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,193 | 42 | $0 (2021) |
| Novo Nordisk Inc | $907.10 | 12 | $0 (2022) |
| PFIZER INC. | $860.30 | 8 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $787.28 | 24 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $638.59 | 8 | $0 (2022) |
| GlaxoSmithKline, LLC. | $581.47 | 29 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $569.58 | 33 | $0 (2022) |
| Lilly USA, LLC | $545.26 | 24 | $0 (2022) |
| Allergan Inc. | $532.65 | 29 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $907.95 | 20 | ABBVIE INC. ($265.21) |
| 2021 | $1,460 | 26 | Amarin Pharma Inc. ($575.36) |
| 2020 | $530.50 | 15 | Lilly USA, LLC ($130.56) |
| 2019 | $1,667 | 52 | AstraZeneca Pharmaceuticals LP ($360.99) |
| 2018 | $3,692 | 87 | Amarin Pharma Inc. ($582.53) |
| 2017 | $3,094 | 122 | Amarin Pharma Inc. ($940.32) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiovascular | ||||||
| 12/01/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Diabetes | ||||||
| 11/29/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $49.37 | General |
| Category: Cardiovascular | ||||||
| 09/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: DIABETES | ||||||
| 09/08/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Diabetes | ||||||
| 09/01/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: Cardiovascular | ||||||
| 08/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.02 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 06/30/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| Category: Cardiovascular | ||||||
| 06/21/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $43.92 | General |
| Category: Cardiovascular | ||||||
| 05/24/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 05/09/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $49.91 | General |
| Category: Cardiovascular | ||||||
| 04/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: Diabetes | ||||||
| 03/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $41.82 | General |
| Category: Cardiovascular | ||||||
| 01/27/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 01/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiovascular | ||||||
| 12/14/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $55.29 | General |
| Category: Cardiovascular | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $58.62 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 8 | 426 | 615 | $114,445 | $43,933 |
| 2021 | 8 | 11,897 | 12,798 | $929,690 | $470,058 |
| 2020 | 7 | 486 | 637 | $80,617 | $25,679 |
Total Patients
12,809
Total Services
14,050
Medicare Billing
$539,670
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 266 | $64,978 | $22,157 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 163 | $27,539 | $10,607 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $8,366 | $4,435 | 53.0% |
| 0003A | Adm sarscov2 30mcg/0.3ml 3rd | Office | 2022 | 95 | 95 | $9,025 | $4,115 | 45.6% |
| 0001A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose | Office | 2022 | 24 | 24 | $2,280 | $1,040 | 45.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $732.00 | $717.36 | 98.0% |
| 0002A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; second dose | Office | 2022 | 11 | 11 | $1,045 | $476.52 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $480.00 | $384.72 | 80.2% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 4,991 | 5,600 | $357,775 | $207,335 | 58.0% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 4,662 | 4,766 | $282,525 | $146,891 | 52.0% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 1,991 | 1,991 | $189,145 | $86,967 | 46.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 321 | $78,414 | $21,370 | 27.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 80 | $13,516 | $3,731 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $3,660 | $1,984 | 54.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $915.00 | $915.00 | 100.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,740 | $864.46 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 245 | $46,687 | $11,874 | 25.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 95 | 95 | $5,795 | $5,763 | 99.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 134 | $18,572 | $3,663 | 19.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 47 | 55 | $4,824 | $2,142 | 44.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 21 | 23 | $3,080 | $1,488 | 48.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2020 | 35 | 35 | $1,110 | $600.28 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 47 | 50 | $550.00 | $148.98 | 27.1% |
About Dr. Howard Keller, MD
Dr. Howard Keller, MD is a Internal Medicine healthcare provider based in Kailua, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124032594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Keller, MD has received a total of $11,351 in payments from pharmaceutical and medical device companies, with $907.95 received in 2022. These payments were reported across 322 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($11,135).
As a Medicare-enrolled provider, Keller has provided services to 12,809 Medicare beneficiaries, totaling 14,050 services with total Medicare billing of $539,670. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Kailua, HI
- Active Since 07/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124032594
Products in Payments
- Vascepa (Drug) $2,660
- FARXIGA (Drug) $889.97
- JARDIANCE (Drug) $668.24
- Livalo (Drug) $569.58
- XARELTO (Drug) $517.41
- EUCRISA (Drug) $498.10
- Ozempic (Drug) $422.55
- VRAYLAR (Drug) $380.75
- ANORO (Drug) $310.10
- BYDUREON (Drug) $279.35
- Ranexa (Drug) $249.42
- RYBELSUS (Drug) $243.82
- COLOGUARD (Device) $235.23
- BYSTOLIC (Drug) $185.07
- UBRELVY (Drug) $179.41
- Axium INS DRG IPG (Device) $147.92
- NAMZARIC (Drug) $143.19
- Superion ISS (Device) $135.76
- ENTRESTO (Drug) $125.00
- Rybelsus (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kailua
Anthony Magliulo, Md, MD
Internal Medicine — Payments: $13,057
Internal Medicine $13,057
Dr. Steven Lum, Md, MD
Internal Medicine — Payments: $11,871
Internal Medicine $11,871
Dr. Clara Yong, M.d, M.D
Internal Medicine — Payments: $4,588
Internal Medicine $4,588
Dr. Sally Chang, M.d, M.D
Internal Medicine — Payments: $3,373
Internal Medicine $3,373
Dr. Helen Ing, M.d, M.D
Internal Medicine — Payments: $2,538
Internal Medicine $2,538
Dr. Sylvia Wang, Md, MD
Internal Medicine — Payments: $2,486
Internal Medicine $2,486